EstroGene

Assesses estrogen metabolism, detoxification, and hormone regulation, offering valuable insights into cancer risks and estrogen-dominant disorders. Given that approximately 80% of breast cancer cases occur in individuals with little to no family history, the test emphasizes the role of estrogen exposure and metabolism as significant risk factors not only for breast cancer but also for ovarian and prostate cancers, as well as estrogen-dominant conditions like endometriosis and premenstrual syndrome.

Senior woman and younger woman smiling together outdoors in a green field.

EstroGene examines genes involved in:

Estrogen Metabolism: Evaluates the efficiency and balance of estrogen processing.

Detoxification Phases I & II: Assesses detox pathways critical in processing and eliminating estrogen.

Factor V: Reviews genetic factors that may influence clotting risk, relevant for those considering hormonal therapies.

Estrogen Hormones: Analyzes hormone levels and interactions that impact overall health.

**This test supports a targeted approach to lifestyle and diet for individuals aiming to manage estrogen-related risks and improve wellness outcomes.

Key Features:

Foundational Health Screening: Suitable for individuals wanting to enhance health outcomes or those with existing conditions like chronic fatigue, cardiovascular disease, or insulin resistance.
Targeted Health Optimization: Useful for those with family histories of cancers linked to estrogen, such as breast, ovarian, colon, or prostate cancer, or for individuals seeking preventative strategies.
Informed Hormone and Fertility Decisions: Provides guidance for individuals considering hormonal treatments (e.g., oral contraceptives, hormone replacement therapy) or in vitro fertilization.